Introduction 1
Physiological and pathophysiological disease conditions can be often characterized by the 2 precise quantification of specific nucleic acid biomarkers. There are several methods 3 available enabling detection of RNA-or DNA-based biomarkers but recently, next-generation 4 sequencing (NGS) has become one of the favourite approaches because of its high 5 sensitivity, high-throughput and flexibility. However, despite of its advantages, the relatively 6 high cost of NGS limits its wider application in healthcare. In addition, common NGS assays 7 consist of multiple laboratory steps that often introduce technical biases limiting accurate 8 quantification and therefore hinder the robust and clinically valid detection of biomarkers 9 PCR-based method DANSR (digital analysis of selected regions) for cell-free DNA (cfDNA) 23 detection in noninvasive prenatal genetic testing (NIPT). The authors of the latter method 24 report that 384 loci per chromosome 18 and chromosome 21 (altogether 768 loci in a single-25 tube reaction) are sufficient for aneuploidy discrimination, which makes it significantly less 26 complex assay than so far widely used low-coverage whole genome sequencing for NIPT 27 (Sparks et al. 2012 ). However, the strategy where ligation-PCR is combined with NGS 28 ensures high level of multiplexing but suffers from the random ligation at low target nucleic 1 acid levels, and on the polymerase-induced errors in both PCR and sequencing steps 2 (Dabney and Meyer 2012; Kebschull and Zador 2015; McInerney et al. 2014) . As an 3 outcome, above highlighted methods overestimate the original number of studied molecules 4 and are biased by PCR uneven amplification. 5
To overcome amplification bias in NGS and to maximize nucleic acid detection sensitivity, 6
unique molecular identifiers (UMIs, known also as molecular indexes, unique identifiers or 7 molecular barcodes) are applied. UMI is a string of random nucleotides used in library 8 preparation that was recently introduced to genomic DNA analysis (Kivioja et al. 2011) and 9 also in single-cell transcriptome analysis (Islam et al. 2014) . One specific motif out of a large 10 pool of random sequences is incorporated into the original target molecule through 11 oligonucleotides used in library preparation prior to amplification. Later, grouping by identical 12 Similarly to above-mentioned applications, UMIs can also be used in targeted ligation-PCR 17 NGS assays to enable exact quantification of studied biomarker molecules. Taking the 18 previous into account, we developed a novel ligation-and NGS-based method, TAC-seq, 19 targeted allele counting by sequencing method for original molecule counting of plasma 20 cfDNA and RNA-based biomarkers. 21
Results 1

TAC-seq principle and assay design 2
TAC-seq is a single-tube and ligation-based assay that allows absolute biomarker 3 quantification by the use of two UMI sequences in detector oligonucleotide probes. The 4 studied mRNA and cfDNA molecules are uniquely identified using 54-bp-long target 5 complementary sequence that is detected by two side-by-side located TAC-seq probes ( Fig.  6 1A). Once stringent hybridization of the detector probes to the target occurs, a thermostable 7 ligase is introduced, catalyzing the formation of a phosphodiester bond between the 5'-8 phosphate and the 3'-hydroxyl of two side-by-side detector probes. Next, ligated detector-9 target complexes are captured using magnetic beads and amplified by PCR (Supplemental 10 
Experimental evaluation of TAC-seq 1
First, we used External RNA Controls Consortium (ERCC) RNA spike-in controls to validate 2 the technical sensitivity and accuracy of the TAC-seq method. Altogether, 22 spike-in 3 sequences were assayed at various concentrations, ranging from 1 to 3×10 5 molecules per 4 reaction ( Supplemental Table S1 ). The spike-in sequences were then detected with TAC-seq 5 probes, sequenced and counted at different UMI thresholds. The analysis consistently 6 demonstrated a high correlation (Spearman r>0.99, Fig. 1B -C) between input and detected 7 molecules for both relaxed and conservative (n>1 molecules required) UMI thresholds 8 (Shugay et al. 2017 ). These results suggested that conservative UMI thresholds (n≥3 9 molecules required in this case, Fig. 1C ) are justified and applicable for high-coverage 10 sequencing, in which the unfiltered read numbers are significantly higher than the UMI 11 corrected outcome (Shugay et al. 2017 ). With seven technical ERCC replicates, the average 12 1.5×10 6 raw read count per replicate dropped to 5.7×10 3 after UMI correction, demonstrating 13 a 102-fold average PCR redundancy at UMI threshold of 4 (n=4) ( Supplemental Table S1 ). Next, we designed a transcriptome assay to analyze human endometrial linings. We targeted 19 57 endometrial receptivity mRNA transcripts that are potential biomarkers in reproductive 20 medicine for testing embryo implantation compatibility (Altmae et al. 2017 ). Ten endometrial 21 biopsy samples were analyzed by TAC-seq and compared with the levels of selected 57 22 transcripts from full transcriptome RNA sequencing (RNA-seq) data. Principal component 23 analysis of these data showed identical clustering of samples when applied to RNA-seq 24 results and two different TAC-seq assays, carried out with high-(denoted as TAC-seq high , 25
average 25.7×10 6 reads per sample) and low-coverage (TAC-seq low , average 1.23×10 6 reads 26 per sample) sequencing (Fig 2A) . In these analyses, the first component described most of 27 the sample variability (RNA-seq 89.8%, TAC-seq high 79.6%, TAC-seq low 83.0%) and clearly 28 distinguished the pre-receptive and receptive samples (n=5 in both groups, Fig. 2A ), except 1 for one outlier sample both in RNA-seq and TAC-seq analyses. The same sample grouping 2 was confirmed by hierarchical clustering: four pre-receptive samples clustered together with 3 high confidence (approximately unbiased (AU) probability of 100%), and receptive samples 4 clustered together with one outlier sample in all datasets (AU RNA =94%; AU TAC-high =69%; 5 AU TAC-low =81%) ( Fig. 2B and Supplemental Fig. S3 ). 6
In both high-and low-coverage TAC-seq approaches all 57 selected biomarkers were 7 detected, demonstrating a flawless detection across all differentially expressed transcripts. 8
However, high-coverage sequencing analysis revealed that 8-bp UMI causes technical 9 limitation in molecule detection in the upper detection range. Six highly expressed genes met 10 UMI-related saturation and were not precisely quantified (Supplemental Fig. S4 ). This 11 technical limitation can be easily overcome by adding longer UMI nucleotides to detector 12 oligonucleotides or by sequencing with lower coverage. 13
In low-coverage assay we expanded the assay to a 70-plex by adding housekeeping genes 14 (8) and selected ERCC spike-ins (5). We observed that although the assayed housekeeping 15 genes represented 47.4% of all unique reads in this assay, the biomarker-based clustering 16 probability was still high (AU TAC-low =81%) and all of the targeted 57 biomarkers were detected 17 ( Fig. 2B ). Based on these results, we suggest that highly expressed housekeeping genes 18 (eg. ACTB, GAPDH and PPIA) could be excluded from the low-coverage assay, to ensure 19 accurate transcriptome biomarker profiling with only 500,000 sequencing reads. To test the feasibility of TAC-seq with small non-coding microRNAs (miRNA), we selected 49 4 miRNAs from endometrial tissue, which were previously analyzed by small RNA-seq and 5 covered highly variable expression levels from 10 to 4,712 counts per million. TAC-seq 6 detected all 49 assayed miRNAs over 16 analyzed endometrial samples with high 1 reproducibility (Spearman r>0.997, Fig. 3 ) and showed high sensitivity in order to distinguish 2 biologically different pre-receptive and receptive clinical biopsies in unsupervised clustering 3 that were not detected by previous RNA-seq assay (Supplemental Fig. S5 ). 4 5 Due to the nature of miRNAs, short, 20-24-bp target regions were detected using specific 6 probes, and the TAC-seq protocol was modified accordingly (Supplemental Fig. S6 ). 7
Additionally, an in silico prediction based on RNA-seq suggested that the selected set of 8 miRNAs had an extreme nucleotide imbalance (Starega-Roslan et al. 2015) at positions one 9 (G<2%) and five (C<3%), causing potential sequencing failure (Supplemental Fig. S7 ). The 10 limitation was overcome using an adjusted spike-in probe that was designed to compensate 11 for the two less-represented nucleotides at certain positions and therefore balance the whole 12 sequencing run. The custom spike-in was later added to the sequencing reaction, resulting in 13 a balanced nucleotide distribution and a high, 96% pass-filtering read rate (Supplemental 14 
Cell-free DNA detection -trisomy detection using controlled conditions 20
As the last test, we evaluated the potential of the TAC-seq method for NIPT, a widely used 21 NGS-based clinical application. NIPT detects fetal trisomy based on the molecular counting 22 of fetal cfDNA in maternal blood samples. We designed a proof-of-principle trisomy 21 23 detection assay to demonstrate the applicability of the TAC-seq method for absolute cfDNA 1 molecule counting to determine fetal trisomy at different experimentally controlled 'fetal 2 fraction' levels. In the following in vitro aneuploidy detection experiment, we mixed different 3 proportions of gDNA from a chr21 trisomy cell line with a known normal control gDNA. 4
Different proportions of fetal trisomic cfDNA were created to imitate the range of fetal fraction 5 in mothers' circulating cfDNA. gDNAs were sheared by sonication to mimic 160-180 bp 6
cfDNA, mixed to yield 5-30% trisomy proportions and hybridized with TAC-seq detector 7 probes that were designed to target 114 loci along chr2 and chr21. Normal diploid chr2 8 served as a reference. The molecule counts without outliers detected a significant (p=4.8×10 -9 11 , one-tailed Welch's t-test) excess of aneuploid chr21 reads compared to normal chr2 in 10 both trisomy 21 cell line replicates ( Fig. 4A ). 11
12
The detection of trisomy 21 demonstrated a significant difference at the lowest 10% 'fetal 1 cfDNA fraction' in one replicate out of two, which improved even further in case of every 2 additional 5% increase in the 'fetal fraction'. At the 30% 'fetal fraction' level and with a pure 3 chr21 trisomy cell line, both replicates detected a significant difference (Fig. 4B ). The same 4 result was confirmed by an independent whole-genome re-sequencing NIPT assay for the 5 same samples (Bayindir et al. 2015 ) (Supplemental Fig. S9 ). Interestingly, we observed that 6 non-normalized molecule counts showed different median values for chr2 and chr21 in a 7 normal diploid cell line, with the chr2 molecule counts being, on average, 5.3% higher than 8 those of chr21. The trend was confirmed with two independent samples. 9 10 11
Discussion 1
Combining high sensitivity and flexibility of NGS with cost-efficient and precise quantification 2 of targeted methods can enable robust detection of specific nucleic acid biomarkers 3 indicative of (patho)physiological conditions. TAC-seq is an advanced ligation-based NGS 4 method that differs from existing ligation-PCR assays such as MLPA (Schouten et al. 2002) , We detected very high sensitivity correlation over 22 analyzed ERCC spike-in input and 13 detected molecules (Spearman r=0.9958 on Fig. 1D ) with high coverage, ensuring that each 14 UMI coverage was 102×. Based on the coverage, we are confident that very few UMIs have 15 been missed and therefore this outcome is reliable. However, systematic difference appears 16 between lowly-and highly-expressed targets with the number of high copy-number 17 molecules is underestimated (see top-four ERCC spike-ins in Supplemental Table S1 ). This 18 is explained by the length of UMI sequences, causing 'technical saturation'. Eight nucleotide 19
UMIs used in our study have 65 thousand possible sequences, which is well suitable for 20
cfDNA-based trisomy detection as copy numbers of cfDNA in 10 ml of blood remains <5,000 21 and random UMI strings into detector probes may increase the probability of probes self-26 pairing and unspecific ligation. However, UMI-related issues such as 'saturation' and 27 replication-caused novel, 'phantom' UMIs (Smith et al. 2017 ) that should be taken into 1 account in assay design and data analysis. 2 TAC-seq was designed while keeping in mind the main prerequisites of genetic testing 3 laboratories -sensitivity, robustness and cost-efficiency. Sensitivity and molecule counting 4 by UMI was discussed above. Robustness is ensured by single-tube protocol to minimize the 5 risk of allelic drop-out. Furthermore, the approach is dilution-free, meaning that analyzed 6 biomarker molecules together with ligated detector probes are captured and identified by 7 sequencing. The latter is crucial in liquid biopsy samples where each locus is represented 8 only by some thousands of copies. If ligation-based assay with specific probes is used then 9 probe hybridization-compatible target cfDNA copy-number reduces 25% due to the short 10 length of cfDNA (180 bp) as the locus is not detected if it locates closer than 25 bp to cfDNA 11 fragmentation site. enables highly specific hybridization and ligation at temperature over 45˚C. Based on this 20 property of Taq DNA ligase, we have carried out first specific probe-target hybridization at 21 60˚C and thereafter introduced ligase to join the proximity annealed strands at the same 22
temperature. 23
As sequencing contributes to the majority of the NGS cost, it is critical to apply library 24 preparation that supports low-coverage sequencing in routine NGS clinical applications. 25
Cost-effectiveness of TAC-seq is ensured by off-the-shelf reagents and the usage of 26 common instruments in genomic laboratory, such as standard thermocycler and benchtop 27 NGS sequencer. The running cost of TAC-seq is only a fraction of the cost for commonly 1 used NGS applications like whole-genome sequencing for NIPT or RNA-seq for mRNA and 2 miRNA analysis. Setup cost of TAC-seq depends on number of studied loci due to the need 3 of specific detector oligonucleotides (Supplemental Fig. S10 ). Consumables and their 4 approximate prices are listed in Supplemental Table S2 and explained in Methods. Based on 5 our in-house library preparation and sequencing, the total reagent cost for miRNA profiling 6
and cell-free DNA analysis is less than 30 EUR per sample and 26-40 EUR per sample for 7 mRNA biomarker analysis, depending on the sequencing depth. Therefore, TAC-seq has the 8 potential to become a cost-effective alternative for routine NIPT after clinical studies or for 9 detecting the levels of transcriptome biomarkers. 10 TAC-seq probe specificity is ensured by 54 bp-long region on mRNA and gDNA. We 11 developed automated mRNA probe design software (http://nipt.ut.ee/design/ without 12 restrictions in usage and described in Methods) that automates probe design procedure and 13 provides highly specific oligonucleotide sequences with common motifs that are ready for 14 synthesize. Probe design for miRNA molecules is even more straightforward and does not In conclusion, we have developed a novel and highly parallel method to count accurately the 26 number of nucleic acid biomarker molecules in studied samples. Our proof-of-principle study 27 demonstrates that TAC-seq has similar sensitivity to golden standard RNA-seq method in 28 case of mRNA and miRNA application, and can successfully detect the excess of cfDNA 1 molecules (indicative of chromosomal trisomy) in cfDNA-like material. TAC-seq is 2 automation-compatible method that is designed to overcome ligation-and NGS-based 3 limitations in genetic testing laboratory. Although all presented applications need careful 4 clinical validations before they can be utilized, the described method is the base for further 5 specialization and optimization to provide advanced DNA and RNA biomarker screening In the current study, we used the 57 mRNAs identified as potential endometrial receptivity 17 biomarkers for distinguishing the pre-receptive and receptive endometrial samples. A pair of 18 TAC-seq detector DNA oligonucleotide probes (left detector and right detector) was designed 19 for every targeted gene using the special TAC-seq probe design software 20 (http://nipt.ut.ee/design/). All of the oligonucleotides used in this study are listed in 21 Supplemental Table S3 . Both the left and right detectors consisted of a specific sequence 22
(27-bp), an UMI (4-bp) and a left universal sequence or right universal sequence. Each 23 detector pair targeted the coding sequence in the Consensus Coding Sequence Set (CCDS). 24
For genes without CCDS, the most likely transcript was chosen manually from the Ensembl 25 87 database. Selection of the target sequence was based on two criteria. First, the adjacent 26 14-bp, 7-bp from both detector probes around the ligation site, had to be unique against 27 human cDNA (GRCh38) to minimize the likelihood of non-specific hybridization. Next, the 28 unique sequences were ranked according to the distance from the 3'-end of the transcript. 1
Routine genetic testing detectors were preferentially designed close to transcript's 3'-end to 2 minimize the effect of possible RNA degradation caused by sampling and handling if poly-A 3 at the mRNA 3'-end is used for cDNA priming. Additionally, detector-specific regions were 4 filtered by GC-content to determine the optimal melting temperature. The overall GC-content 5 of a probe had to be between 40-60%, and the GC-content of the adjacent ends (4-bp) was 6 up to 50%. Additionally, detector oligonucleotides with inter-or intra-complementarity issues 7
were excluded from the selection. Although mRNA's 3'-ends were targeted in this study, the 8 software has an option to design TAC-seq detectors close to the transcript's 5'-end, if 9 required. The ERCC spike-in 22 detectors were designed based on the above description 10 close to their poly-A tails. used as an input for BLAST 2.4.0+ (task blastn) with database version GRCh38 23 (GCA_000001405.15). All reads with more than one exact match were removed, following 24 the concatenation of overlapping regions. The regions were converted to sequences with 25 UCSC Genome Browser Gateway. Altogether, 114 specific detector pairs over the studied 26 chromosomes 2 and 21 were selected according to the above-described design, ensuring 27 equal coverage over the entire chromosome. 28 1 ERCC mRNA library preparation 2 Non-skirted low profile PCR Strip Tube Plates (Thermo Fisher) were used with domed cap 3 strips (Thermo Fisher). ERCC Spike-In Mix 1 (Life Technologies) was first diluted 10× and 4 then additionally 100× with water. Aliquots, each containing 1.3 µl of 1,000× dilution, were 5 stored at -70°C until use. Next, 199 µl of water was added to 1.3 µl aliquot and mixed. 1 µl of 6 diluted ERCC spike-in content ( Supplemental Table S1 ), serving as a template for each 7 individual library was added to 2 µl of denaturation buffer, containing 5 mM Tris-HCl (pH 7.0) 8 (Sigma-Aldrich), 1 mM dNTP mixture (Thermo Fisher), 400 nM Oligo-T30 primer and 0.05% 9 Triton X-100 (Sigma-Aldrich). Reaction was mixed by pipetting and centrifuged briefly. Minus Reverse Transcriptase (Thermo Fisher) was prepared. The master mix was vortexed 15 and briefly centrifuged. 2 µl of RT master mix was added to previously denatured RNA (3 µl). 16
All RT pipetting steps were performed on ice. cDNA synthesis was performed by 30 min at 17 42°C, following 5 min at 85°C for RT inactivation. 18
Twenty two TAC-seq detector pairs targeting ERCC spike-in molecules were previously 19 mixed together from 100 µM stock solutions, creating a '100 µM' oligo pool. The oligo mixture 20 was diluted to 5 µM by water and stored at -20°C. Once cDNA synthesis was completed, 1 µl 21 of 5 µM TAC-seq detector mixture was added to RT mixture. The content was mixed on 22 vortex and centrifuged briefly. Strip tubes were placed on thermocycler, cDNA denatured for 23 1 min at 98°C, followed by 1 h at 60°C to enable specific cDNA and TAC-seq probe 24 hybridization. After hybridization, thermostable ligase reaction mixture was added. To keep a 25 constant hybridization temperature (60°C), the cycler lid was opened and strip caps were 26 removed. 5 µl of Taq DNA ligase master mix, containing 2× Taq DNA ligation buffer (New 27
England Biolabs, NEB) and 1 U Taq DNA ligase (NEB) were added to each individual 28 reaction tube and mixed by pipetting. The strip tubes were not removed from 60°C 1 thermocycler to avoid self-and mispairing of TAC-seq probes. Ligation reaction was stopped 2 after 20 min incubation by placing the reaction tubes on ice. 3 15 µl of mixture consisting of Dynabeads MyOne Carboxylic Acid beads (2 µl) (Thermo 4 Fisher) and 13 µl of capture buffer (30% PEG-6000, 2 M NaCl, 5 mM Tris-HCl (pH 7.5), 10 5 mM EDTA and 0.02% Tween-20 (all chemicals from Sigma-Aldrich)) was added to ice-6 cooled ligated sample. The content was mixed by vortex. Capture was carried out for 10 min 7 at room temperature. After that the tubes were placed on DynaMag-96 Side Magnet (Thermo 8
Fisher) holding 8-well strip tubes on VersiPlate Frame (Thermo Fisher). Supernatant was 9 removed after 3 min incubation on the magnet. The beads on magnet were washed once 10 with 50 µl of fresh 80% ethanol. Ethanol was removed by pipetting, and the clean pellet, 11 without ethanol drops, was dried for 2 min. Once beads were dry, strip tubes were removed 12 from the magnet and 18 µl of PCR master mix was added directly to the beads. We have 13 also successfully performed magnetic bead capture prior PCR without ethanol washing to 14 avoid the risk of over-drying the bead. In the latter case, the supernatant should be removed 15 completely. PCR master mix contained 1× proofreading HOT FIREPol Blend Master Mix 16 (Solis BioDyne, Tartu, Estonia) and 250 nM TAC-seq left primer. In addition to universal 17 TAC-seq left, 16 different TAC-seq barcoded oligonucleotides were used to introduce a 6-bp 18 barcode to each studied sample (Supplemental Table S3 ). For that, 2 µl of 5 µM TAC-seq 19 barcoded 1-16 primers were added individually to each PCR reaction. Strip tubes were 20 closed with clean domed caps, mixed on vortex until beads were completely re-suspended. 21
The ERCC spike-in reaction was incubated at 95°C for 12 min, followed by two cycles of 22 95°C for 20 s, 57°C for 60 s and 72°C for 20 s. In addition, 16 cycles of 95°C for 20 s, 65°C 23 for 20 s and 72°C for 20 s with a final extension at 72°C for 1 min using the default ramp 24 speed of the T100 cycler (Bio-Rad) were performed. PCR products were pooled together into 25 1.5 ml tube. The tube with pooled sample was placed on magnet to remove carboxylated 26 beads before the following column purification. Clear supernatant was purified with DNA 27
Clean & Concentrator-5 column (Zymo Research) and eluted with 50 µl of elution buffer (EB). 28
The library was size-selected using AMPure XP beads (Beckman Coulter) in a single-step 1 selection to reduce 81 bp linear PCR double-stranded by-product (Supplement Fig. S1 ). 50 2 µl beads were added to 50 µl of the purified PCR product, incubated for 5 min at room 3 temperature and captured by a magnet for 3 min. After incubation on magnet, the 4 supernatant was discarded and the remaining beads were centrifuged at 500×g for 10 s. 5
After centrifugation, the beads were placed again on the magnet and all remaining 6 supernatant was removed. The beads were eluted directly without ethanol washing in 25 µl 7 of EB and incubated for 1 min at room temperature. AMPure XP bead elution has almost 8 100% efficiency even without previous ethanol wash. Finally, the eluted library was 9 transferred to a clean tube after 1 min incubation on the magnet. The 180 bp library 10 (Supplemental Fig. S1A-D) was visualized on a TapeStation High Sensitivity D1000 11
ScreenTape (Agilent Technologies) and quantified using KAPA Library Quantification Kit 12 (Roche). 13 14 Clinical sample mRNA library preparation 15 mRNA biomarker libraries for endometrial receptivity testing were prepared as described 16
above with the following modifications. Total-RNA samples with RIN values 7.7-9.6 17 (quantified by Qubit (Invitrogen)) were diluted to concentration of 90 ng/µl and 1 µl of this was 18 used for library preparation. RT master mix contained 1 µl of 1:50,000 of ERCC RNA Spike-19
In Mix 1 (Life Technologies) dilution for technical normalization. Altogether 64-plex TAC-seq 20 probe set, containing 57 biomarker genes (Altmae et al. 2017 ) and seven ERCC spike-ins 21 (ERCC-00085; 00170; 00019; 00131; 00092; 00108 and 00004) were used to generate a 22 library for high-coverage analysis. The low-coverage analysis was performed using 70-plex, 23 containing 57 biomarker genes (Altmae et al. 2017), five ERCC spike-ins (00131; 00108; 24 00092; 00019 and 00004) and eight housekeeping genes (ACTB, GAPDH, YWHAZ, PPIA, 25 CYC1, HMBS, TBP and SDHA). 5 µM detector oligonucleotide mixtures from 100 µM stocks 26 were created as described above. PCR was performed using in total 12 cycles, following 27 2+10 principle (described in details above) for both high-and low-coverage libraries. 28 1 microRNA library preparation 2 miRNA profiles were analysed from endometrial total-RNA. 3' ligation was carried out 3 overnight in 5 µl volume. The reaction contained 100 ng of total-RNA, 1× RNA T4 RNA 4
Ligase Reaction Buffer (NEB), 20 U RNase inhibitor (Thermo Fisher), 10% PEG-8000 (NEB), 5 100 nM adenylated 3' linker and 40 U T4 RNA ligase 2 (truncated, NEB). After ligation, the 6 free ligation adapter was removed by adding 0.5 µl 5'-Deadenylase (25 U/µl, NEB) and 0.5 µl 7
Lambda exonuclease (5 U/µl, NEB) and incubated 10 min at 37°C, followed by 10 min at 8 Transcriptase (200 U/µl, Thermo Fisher) which were mixed into one 2 µl master mix. cDNA 12 incubation was carried out for 15 min at 50°C, followed by 5 min at 80°C. Unbound primers 13 were removed by adding 1 µl Exonuclease I (20 U/µl, Thermo Fisher) and incubating for 10 14 min at 37°C and 5 min at 95°C. 1 µl of 5 µM TAC-seq detector mixture, containing miRNA-15 specific left detectors and miRNA universal 5' phosphorylated detector oligonucleotide 16 (Supplemental Fig. S6 ), was added to previous 9 µl product and incubated first for 2 min at 17 98°C to denature the template and probes and then for 1 h at 60°C. After the hybridization, 18 thermostable ligase reaction mixture was added on thermocycler, keeping a constant (60°C) 19 hybridization temperature. The cycler lid was opened and strip caps were removed. 5 µl of 20
Taq DNA ligase mixture, containing 2× Taq DNA ligation buffer (NEB) and 1 U Taq DNA 21 ligase (NEB) was added to each individual reaction tube and mixed by pipetting. Ligation was 22 stopped after 20 min incubation by placing reaction tubes on ice. 3 µl of Dynabeads MyOne 23
Streptavidin C1 beads (Invitrogen) were washed according to protocol and suspended in 15 24 µl recommended B&W buffer. The beads were added to ligated product on ice, mixed well by 25 pipetting and incubated for 10 min at room temperature. After capturing the beads on magnet 26 for 1 min, the supernatant was removed and the beads were washed once with B&W buffer. 27 TAC-seq ligated detectors were amplified as described above using 2+18 cycles of PCR. 1
The designed miRNA library is 170 bp (Supplemental Fig. S1E) . Fisher) and 22 µl of capture buffer as described above was used for capture in this assay. 19
Ligated TAC-seq detectors were amplified as above described using 2+19 PCR cycles. 20 21
MicroRNA spike-in preparation 22
Custom miRNA spike-in was prepared with PCR using 76 bp synthetic 'miRNA spike-in' 23 oligonucleotide, 'TAC-seq left' and 'miRNA spike-in right primer' ( Supplemental Table S3 ). reads. The RNA-seq data was analyzed as previously described (Altmae et al. 2017) . 10
Heatmaps of the results were generated using the 'pheatmap' package implemented in R. 11
For plotting, CPM values provided by edgeR were log-transformed, using the transformation 12 log(CPM+1) to facilitate graphical presentation of the results. 13
Previously published small RNA sequencing data, containing the same RNA samples as in 14 the miRNA TAC-seq experiments, was used. Briefly, libraries were constructed following a 15
TruSeq Small RNA Library Preparation Guide (Illumina). 1 µg of small RNA fraction isolated 16 from endometrial tissues was used as an input. Libraries were sequenced by Illumina HiSeq 17 2500 instrument producing 50 bp single-end reads. The RNA-seq data was analyzed as 18 previously described (Altmae et al. 2017) . 19
Sheared genomic DNA samples with concentration 5 ng/µl were used to generate cfDNA 20 libraries as described elsewhere but using 12 cycles of PCR. Libraries were quantified by 21
Qubit HS assay (Thermo Fisher), brought to the uniform concentration and pooled. The 22 pooled library quality was estimated using a TapeStation High Sensitivity D1000 ScreenTape 23 (Agilent Technologies) and sequenced by Illumina NextSeq 500 instrument producing 85 bp 24 single-end reads. A previously described method was used for the analysis including 25 mapping of sequencing reads to the reference genome, calculating the coverage of each 26 region in the genome, GC correction, calculating the mean and standard deviation of the 27 reference population and the sample. Finally, risk for aneuploidy was estimated by 28 calculating Z-score, as well as additional ZZ-score, BM (bin median) and OM (other median). 1
Trisomy is called if Z-score is ≥ 3, ZZ-score is ≥ 3, BM is ≥ 1.5 and OM is < 1 (Supplemental 2 The ERCC spike-in library was sequenced by Illumina NextSeq 500 high output 75 cycles kit 6 using 2 pM library concentration. The library was sequenced using 90-bp single-read 7 protocol that was primed by Illumina Read1 (HP10) primer. The entire construct was 90-bp. 8
The second, high-coverage mRNA biomarker set was sequenced with configuration identical 9 to the one described above. In both libraries, particularly in receptivity biomarker assay, 2-10 channel Illumina SBS technology caused reduced level of cluster quality due to a common 11 20-bp motif (an extremely low-diversity region) at construct 62-82-bp site (Supplemental Fig.  12 8A). 4-channel SBS was used with the same library and 90-bp read using MiSeq (Illumina) 13 instrument (data not shown) without any improvement. Following custom barcode 14 sequencing primer was designed and used for low-coverage mRNA biomarker assay, 15 analyzed by MiSeq Reagent Kit v3 in 14 pM library concentration. Custom barcode primer 16 avoided the low-diversity common region and significantly improved the outcome, increasing 17 the chastity filter (pass-filter) per cent from previous 67% to 93% (Supplemental Fig. S8B-D) . 18
In total 62-bp Read1 and 6-bp barcode (index) nucleotides were sequenced. miRNA library 19 was sequenced by NextSeq 500 high output 75 cycles kit and 2 pM library concentration 20 using LNA custom barcode primer. The Read1 length was 32-bp plus 6-bp barcode. Cell-free 21 
TAC-seq data analysis 1
ERCC spike-in reads were trimmed to construct length of 88-bp and demultiplexed by 2 barcodes (6-bp) allowing 1 mismatch. Demultiplexed reads were further trimmed to length of 3 62-bp and 4-bp of UMI at the end of the read was inserted after 4-bp of the UMI at the start 4 of the read. Reads with UMI that contained unallocated nucleotides, were discarded. 5
Resulting reads per sample were demultiplexed again using target regions of the genes (54-6 bp) allowing up to 5 mismatches. Total read counts, unique molecule counts and Pearson 7
and Spearman correlations were calculated at different UMI thresholds. Due to the fact that 8
Pearson method assumes linear correlation and therefore resulted in insensitive correlations 9 at high UMI thresholds, we chose Spearman correlation as it proved to work correctly in case 10 of very high and very low molecule concentrations. 11
Gene expression reads were processed as described above. To reduce potential sequencing 12 error accumulating at UMI motif, only reads appearing at least twice were counted as unique 13 molecules (UMI=2). Each sample was normalized to CPM using edgeR (version 3.18.1) 14 package in R (version 3.4.1) and log-transformed using the log10 (CPM+1) transformation to 15 reduce skewness. In addition to biomarker genes, both high-and low-coverage TAC-seq 16 libraries included spike-in molecules. Furthermore, the low-coverage library included eight 17 housekeeping genes which were taken into account in CPM normalization. The normalization 18 procedure was based on the published formula that was further adjusted for read count data. 19
Genomic DNA sequencing data quality control and pre-processing were performed as 20 described above. Loci that were 1.5 interquartile ranges (IQRs) below the first quartile or 21 above the third quartile were called as outliers and removed. As we constantly detected 22 slightly higher molecule counts in chr2 compared to chr21 in euploid samples, chromosome-23 specific molecule counts were applied. For that, mean molecule counts of chr2 and chr21 24 (~1.081 at UMI threshold 2) using the euploid samples were calculated and used for 25 normalization. User-friendly software was developed to enable TAC-seq data processing in Targeted assay setup needs two specific probe oligonucleotides for mRNA and cfDNA 5 analysis. The price we got from synthesis company was 27 EUR per detector pair, resulting 6 in 800 EUR in total for 30 loci analysis, for example ( Supplemental Fig. S10A ). miRNA 7 detection needs only one non-phosphorylated specific detector per molecule of interest 8 (Supplemental Fig. S6 ), lowering the setup cost to 200 EUR in case of 30 loci. Reagent 9 costs, using off-the-shelf consumables, show that cDNA synthesis for mRNA assay is 0.6 10 EUR per entire sample that is more cost-effective than miRNA cDNA synthesis (3.2 11 EUR/sample) that needs more manipulations. Following ligation, purification and quality 12 control cost 5.4 EUR for mRNA, miRNA and cfDNA applications ( Supplemental Table S2 ). 
